Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?

Purpose. To determine if the MMP-9 genotype has an influence on development of pituitary adenoma (PA). Methodology. The study enrolled n = 86 patients with PA and n = 526 healthy controls (reference group). The genotyping of MMP-9 was carried out using the real-time polymerase chain reaction method. Results. Our data demonstrated that the MMP-9 (–1562) C/C genotype was more frequent in PA group than in healthy controls (81.4% versus 64.6%, p = 0.002); C/C genotype was more frequently present in PA females compared to healthy control females, 81.5% versus 64.6%, p = 0.018, as well. MMP-9 (–1562) C/C genotype was frequently observed for all subgroups: noninvasive and invasive, nonrecurrence, and inactive PA compared to healthy controls: 81.8% versus 64.6%, p = 0.021; 81.0% versus 64.6%, p = 0.041; 81.8% versus 64.6%, p = 0.005; 100.0% versus 64.6%, p < 0.001, respectively. MMP-9 (–1562) C/C genotype was more frequent in inactive PA compared to active PA: 100.0% versus 71.4%; p < 0.001. Conclusion. MMP-9 (–1562) C/C genotype plays a role in nonrecurrence, inactive, and invasive as well as in nonivasive PA development.

[1]  J. S. Andrade-Filho,et al.  Matrix metalloproteinase 9 -1562C/T polymorphism increased protein levels in patients with colorectal cancer in a sample from southeastern Brazil. , 2016, Genetics and molecular research : GMR.

[2]  A. Tamašauskas,et al.  Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma , 2016, Scientifica.

[3]  S. Ceylan,et al.  Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas , 2015, Journal of Clinical Neuroscience.

[4]  F. Di Salle,et al.  Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study , 2014, Pituitary.

[5]  Mehdi Mohsenzadeh,et al.  Association of MMP 9-1562 C/T single nucleotide polymorphism with the susceptibility to lung cancer disease in south Iranian population. , 2014 .

[6]  John W. Chen,et al.  Identification of small compound biomarkers of pituitary adenoma: a bilateral inferior petrosal sinus sampling study , 2013, Journal of NeuroInterventional Surgery.

[7]  J. Didziapetriene,et al.  Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer. , 2013, Tumori.

[8]  P. Nallari,et al.  MMP 9 Gene Promoter Polymorphism in Gastric Cancer , 2012, Indian Journal of Clinical Biochemistry.

[9]  B. Heude,et al.  Cognitive restraint, uncontrolled eating and emotional eating: correlations between parent and adolescent. , 2009, Maternal & child nutrition.

[10]  Li Jiang,et al.  Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer. , 2007, World journal of gastroenterology.

[11]  K. Tsuneyama,et al.  Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. , 2006, Anticancer research.

[12]  C. V. D. van de Velde,et al.  Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer , 2006, British Journal of Cancer.

[13]  K. Kunishio,et al.  Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. , 2005, The journal of medical investigation : JMI.

[14]  W. Wilczak,et al.  Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue , 2003, Acta Neuropathologica.

[15]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[16]  M. Mareel,et al.  Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.

[17]  Y. Eishi,et al.  Expression of Matrix Metalloproteinase-9 and Bombesin/Gastrin-Releasing Peptide in Human Prostate Cancers and their Lymph Node Metastases , 2002, Acta oncologica.

[18]  K. Kovacs,et al.  Classification of pituitary adenomas , 2001, Journal of Neuro-Oncology.

[19]  M. Vance,et al.  Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. , 2001, The Journal of clinical endocrinology and metabolism.

[20]  A. Henney,et al.  Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1 , 1999, Human Genetics.

[21]  A. Gatherer.  Clinical , 1997 .

[22]  C. Matula,et al.  Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. , 1993, Neurosurgery.

[23]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[24]  B. Scheithauer,et al.  Pathology of invasive pituitary tumors with special reference to functional classification. , 1986, Journal of neurosurgery.

[25]  W. Hager,et al.  and s , 2019, Shallow Water Hydraulics.

[26]  W. Marsden.  I and J , 2012 .

[27]  M. Sadeghi,et al.  MMP-9 promoter polymorphism associated with tumor progression of breast cancer in Iranian population , 2009 .

[28]  E. Laws,et al.  Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas , 2007, Pituitary.

[29]  Z. Fang,et al.  Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. , 2007, The American journal of pathology.

[30]  K. Kurisu,et al.  Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis , 2005, Acta Neurochirurgica.

[31]  Kazuhiro Yoshida,et al.  A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[32]  A. Harris,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Role of Matrix Metalloproteinase 9 in Pituitary Tumor Behavior , 2000 .

[33]  U. Renner,et al.  High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells. , 2000, The Journal of clinical endocrinology and metabolism.